𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Porphyria cutanea tarda in a patient with acute leukemia

✍ Scribed by Janice P. Dutcher; Michael Fisher; Morton Spivack; Peter H. Wiernik

Publisher
John Wiley and Sons
Year
1986
Tongue
English
Weight
513 KB
Volume
23
Category
Article
ISSN
0361-8609

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Extremely rare association of HFE mutati
Extremely rare association of HFE mutations with porphyria cutanea tarda in japanese patients
✍ Kazumichi Furuyama; Masao Kondo; Kenji Hirata; Hiroyoshi Fujita; Shigeru Sassa 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 48 KB 👁 1 views

et al. 6 who also found no association between the C282Y mutation and SPCT. The H63D mutation was observed in 10 of the 48 PCT patients corresponding to 20.8%. Of the 10 individuals diagnosed, 4 belonged to the familial form of PCT and 6 to the sporadic form. The mutations detected were all heteroz

Hepatitis C virus antibodies and liver d
Hepatitis C virus antibodies and liver disease in patients with porphyria cutanea tarda
✍ Mar Decastro; Javier Sánchez; Jesús F. Herrera; Asunción Cháves; Rafael Durán; L 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 1011 KB

The recent identification of the hepatitis C virus and development of assays to detect antibodies to hepatitis C virus has allowed assessment of the prevalence of hepatitis C virus infection in patients with a variety of liver and other diseases. The aim of this study was to investigate the prevalen

Severe radiation therapy–related soft ti
Severe radiation therapy–related soft tissue toxicity in a patient with porphyria cutanea tarda: A literature review
✍ G. Brandon Gunn; Karl E. Anderson; Abhilasha J. Patel; Juan Gallegos; Csilla Kor 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 202 KB

## Abstract ## Background. Some porphyrias are associated with cutaneous phototoxicity due to photoactivation of porphyrins, but whether ionizing radiation can have an additive effect is not clear. We report a case of severe radiation therapy‐related toxicity in a patient with porphyria cutanea ta

High prevalence of the His63Asp HFE muta
High prevalence of the His63Asp HFE mutation in italian patients with porphyria cutanea tarda
✍ Maurizio Sampietro; Alberto Piperno; Loredana Lupica; Cristina Arosio; Anna Verg 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 67 KB 👁 1 views

Sporadic porphyria cutanea tarda (PCT) is caused by a reduced activity of uroporphyrinogen decarboxylase (URO-D) in the liver. Mild to moderate iron overload is common in PCT, as iron is one of the factors which trigger the clinical manifestations of the disease through the inactivation of URO-D. A